(Q42990670)

12 November 2017

1 reference

title

The natural course of chronic hepatitis C: implications for clinical practice (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Dusheiko GM

1

1 reference

12 November 2017

publication date

1 September 1998

1 reference

Journal of Viral Hepatitis

12 November 2017

published in

1 reference

12 November 2017

volume

5 Suppl 1

1 reference

12 November 2017

page(s)

9-12

1 reference

Chronic hepatitis C: beware the older drinking male: fibrosis progression beckons!

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Clinical outcomes after transfusion-associated hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Mortality from liver cancer and liver disease in haemophilic men and boys in UK given blood products contaminated with hepatitis C. UK Haemophilia Centre Directors' Organisation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Slow progression rate of fibrosis in hepatitis C virus patients with persistently normal alanine transaminase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Re-treatment of chronic hepatitis C with consensus interferon .

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

The long-term pathological evolution of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

Morbidity and mortality in compensated cirrhosis type C: a retrospective follow-up study of 384 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2893.1998.0050S1009.X

10.1046/J.1365-2893.1998.0050S1009.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference